{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:36:38Z","timestamp":1790228198627,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical and Translational Science","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,5]]},"DOI":"10.1093\/infdis\/jiy411","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T07:28:59Z","timestamp":1530257339000},"page":"1883-1889","source":"Crossref","is-referenced-by-count":22,"title":["A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus"],"prefix":"10.1093","volume":"218","author":[{"given":"Stephanie S","family":"Anguiano-Zarate","sequence":"first","affiliation":[{"name":"Clinical Translational Sciences Graduate Program, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E","family":"Matchett","sequence":"additional","affiliation":[{"name":"Virology and Gene Therapy Graduate Program, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod N","family":"Nehete","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Texas M. D. Anderson Cancer Center, Houston and Bastrop, Texas"},{"name":"Department of Veterinary Sciences, University of Texas M. D. Anderson Cancer Center, Houston and Bastrop, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagannadha K","family":"Sastry","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Texas M. D. Anderson Cancer Center, Houston and Bastrop, Texas"},{"name":"Department of Veterinary Sciences, University of Texas M. D. Anderson Cancer Center, Houston and Bastrop, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marzi","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Barry","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Immunology, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"key\n\t\t\t\t2018110510355005500_CIT0001","volume-title":"Analysis of Ebola glycoprotein sequences from strains of varying lethality","author":"Doukas","year":"2002"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0002","first-page":"1279","article-title":"Filoviridae: Marburg and Ebola viruses","volume-title":"Fields virology","author":"Sanchez","year":"2001","edition":"4"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0003","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0004","first-page":"548","article-title":"Ebola viral disease outbreak\u2013West Africa, 2014","volume":"63","author":"Dixon","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0005","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMcibr051754","article-title":"How ebola virus infects cells","volume":"352","author":"Yoshihiro","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0006","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.01810-14","article-title":"Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity","volume":"89","author":"Mohan","year":"2015","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0007","volume-title":"Ebola R&D landscape of clinical candidates and trials","author":"World Health Organization (WHO)","year":"2015"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0008","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.su6503a14","article-title":"Implementing an Ebola vaccine study\u2014Sierra Leone","author":"Widdowson","year":"2016","journal-title":"MMWR Suppl: Centers for Disease Control"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0009","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A Recombinant Vesicular Stomatitis Virus Ebola Vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0011","doi-asserted-by":"crossref","first-page":"e0004802","DOI":"10.1371\/journal.pntd.0004802","article-title":"Next steps for Ebola vaccination: deployment in non-epidemic, high-risk settings","volume":"10","author":"Skrip","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0012","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0013","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0014","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase \u00bd trial","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1473-3099(15)00222-4","article-title":"Use of low dose rVSV-ZEBOV: safety issues in a Swiss cohort","volume":"15","author":"Ledgerwood","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0016","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A monovalent Chimpanzee adenovirus Ebola vaccine boosted with MVA","volume":"374","author":"Ewer","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0017","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1410863","article-title":"Chimpanzee adenovirus vector Ebola vaccine","volume":"376","author":"Ledgerwood","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/2051013615611017","article-title":"Clinical development of Ebola vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Ther Adv Vaccines"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0019","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","article-title":"Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0021","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/vim.2005.18.657","article-title":"Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these","volume":"18","author":"Maeda","year":"2005","journal-title":"Viral Immunol"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0022","doi-asserted-by":"crossref","first-page":"e00720","DOI":"10.1128\/JVI.00720-16","article-title":"Replicating single-cycle adenovirus vectors generate amplified influenza vaccine responses","volume":"91","author":"Crosby","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0023","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1128\/JVI.02184-14","article-title":"Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines","volume":"89","author":"Crosby","year":"2015","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0024","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.virol.2014.05.030","article-title":"IIIa deleted adenovirus as a single- cycle genome replicating vector","volume":"462-463","author":"Crosby","year":"2014","journal-title":"Virology"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0025","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/nar\/20.7.1785","article-title":"Modifications of the E.coli Lac repressor for expression in eukaryotic cells: effects of nuclear signal sequences on protein activity and nuclear accumulation","volume":"20","author":"Fieck","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0026","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm0797-808","article-title":"Sensitivity and reproducibility in adenoviral infectious titer determination","volume":"3","author":"Nyberg-Hoffman","year":"1997","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0027","doi-asserted-by":"crossref","first-page":"S1066","DOI":"10.1093\/infdis\/jir348","article-title":"Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy","volume":"204","author":"Marzi","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"issue":"(2)","key":"key\n\t\t\t\t2018110510355005500_CIT0029","article-title":"Transgene expression and host cell responses to replication-defective, single-cycle, and replication-competent adenovirus vectors","volume":"8","author":"Crosby","year":"2017","journal-title":"Genes"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0030","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1542\/peds.101.6.1013","article-title":"Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors","volume":"101","author":"Piedra","year":"1998","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0031","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0032","first-page":"169","article-title":"Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors","volume":"130","author":"Thomas","year":"2007","journal-title":"Methods Mol Med"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0033","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","article-title":"Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier","volume":"77","author":"Xiang","year":"2003","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0034","doi-asserted-by":"crossref","first-page":"4","DOI":"10.32607\/20758251-2017-9-3-4-11","article-title":"Virus-Vectored Ebola Vaccines","volume":"9","author":"Dolzhikova","year":"2017","journal-title":"Acta Naturae"},{"key":"key\n\t\t\t\t2018110510355005500_CIT0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/21645515.2016.1238535","article-title":"Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I\/II trial in healthy adults in Russia","volume":"13","author":"Dolzhikova","year":"2017","journal-title":"Hum Vaccin Immunother"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/12\/1883\/26362818\/jiy411.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T00:50:12Z","timestamp":1571532612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/12\/1883\/5049708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,7,6]]},"published-print":{"date-parts":[[2018,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy411","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,7,6]]}}}